Myriad Genetics Inc - Company Profile
Powered by 
All the data and insights you need on Myriad Genetics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Myriad Genetics Inc Strategy Report
- Understand Myriad Genetics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Myriad Genetics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20220284985A1 | Application | METHOD FOR DETECTING GENETIC VARIATION IN HIGHLY HOMOLOGOUS SEQUENCES BY INDEPENDENT ALIGNMENT AND PAIRING OF SEQUENCE READS | C12Q1/6869; C12Q2600/156; G16B20/00; G16B30/10; G16B40/20 | September 08, 2022 |
| WO2022182870A1 | Application | GLOBAL POLYGENIC RISK ASSESSMENT FOR BREAST CANCER | September 01, 2022 | |
| AU2022211880A1 | Application | METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY | A61K33/243; A61P1/04; A61P15/00; A61P35/00; A61P43/00; C12Q1/6827; C12Q1/6858; C12Q1/6886; C12Q2600/106; C12Q2600/154; C12Q2600/156; G16B20/00; G16B20/20 | September 01, 2022 |
| US20220267837A1 | Application | METHODS FOR IDENTIFYING CARRIER STATUS AND ASSESSING RISK FOR SPINAL MUSCULAR ATROPHY | C12Q1/6827; C12Q2600/156 | August 25, 2022 |
| US20220259675A1 | Application | GENE SIGNATURES FOR CANCER PROGNOSIS | C12Q1/6886; C12Q2600/118; C12Q2600/156; C12Q2600/158 | August 18, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer